Document Detail


Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
MedLine Citation:
PMID:  15963699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The recurrence of flashbacks without acute or chronic hallucinogen consumption has been recognized in the DSM IV criteria as the hallucinogen persisting perception disorder (HPPD). Perceptual disturbances may last for 5 years or more and represent a real psychosocial distress. We reported here a case of a 18-year-old young man presenting HPPD after a mixed intoxication with psylocibin and cannabis. This report shows symptomatic recurrences persisting more than 8 months. Various differential diagnoses were evoked and our therapeutic strategies were described.
Authors:
Marie-Laure Espiard; Laurent Lecardeur; Pascale Abadie; Isabelle Halbecq; Sonia Dollfus
Related Documents :
17261449 - Esophageal involvement as an initial manifestation of churg-strauss syndrome.
1630429 - Outbreak of type e botulism associated with an uneviscerated, salt-cured fish product--...
7600819 - Corneal subepithelial infiltrate recurrence sine adenovirus.
3291939 - Indomethacin retinopathy: case report and review.
23347849 - Some improvements are apparent in identifying adverse effects in systematic reviews fro...
23396309 - Swelling of the submandibular glands after administration of low-osmolarity contrast ag...
24679999 - What's new in objective assessment and treatment of facial hyperpigmentation?
16924199 - Ventral thoracic spinal cord herniation: frequently misdiagnosed entity.
8740749 - Fatal spontaneous rupture of a gravid uterus: case report and literature review of uter...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European psychiatry : the journal of the Association of European Psychiatrists     Volume:  20     ISSN:  0924-9338     ISO Abbreviation:  Eur. Psychiatry     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-09-20     Completed Date:  2006-02-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111820     Medline TA:  Eur Psychiatry     Country:  France    
Other Details:
Languages:  eng     Pagination:  458-60     Citation Subset:  IM    
Affiliation:
Centre Esquirol, Centre Hospitalier Universitaire de Caen, 14033 Caen cedex, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antidepressive Agents / therapeutic use
Antipsychotic Agents / therapeutic use
Anxiety / chemically induced,  drug therapy,  psychology
Depressive Disorder / chemically induced,  drug therapy,  psychology
Diagnosis, Differential
Hallucinogens / adverse effects*
Humans
Male
Marijuana Smoking
Perceptual Disorders / chemically induced*,  diagnosis*,  drug therapy
Psilocybine / adverse effects*
Psychiatric Status Rating Scales
Recurrence
Risperidone / therapeutic use
Sertraline / therapeutic use
Social Behavior Disorders / chemically induced,  drug therapy,  psychology
Time Factors
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/Antipsychotic Agents; 0/Hallucinogens; 106266-06-2/Risperidone; 520-52-5/Psilocybine; 79617-96-2/Sertraline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Research on mental disorders and their care in immigrant populations: a review of publications from ...
Next Document:  Prevalence and incidence of Parkinson's disease in Europe.